Rani Therapeutics Holdings, Inc.
RANI· Nasdaq
Released Feb 23, 2022, before the open
10-K filed Mar 31, 2022, 90 days after period end · 0000950170-22-005088
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|
| Revenue | $0.00 | — |
| Net Income | $5.89M | -$5.76M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rani Therapeutics Holdings, Inc. · CIK 1856725 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Mar 31, 2022 · 90 d after period end
19.0% from the close of Feb 18, 2022 to the close of Feb 23, 2022, the first after the release.